Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Connective tissue diseases Stories

2013-04-24 12:29:17

CINCINNATI, April 24, 2013 /PRNewswire-USNewswire/ -- Researchers report in Nature Genetics they have increased the number of confirmed genes linked to juvenile idiopathic arthritis (JIA) from three to 17 - a finding that will clarify how JIA fits into the spectrum of autoimmune disorders and help identify potential treatment targets. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Published April 21, the study involves an international research team that analyzed 2,816 JIA...

2013-04-24 08:30:27

Surveyed US Rheumatologists Believe Actemra is Most at Risk for Displacement by Xeljanz, According to a New Report from BioTrends Research Group EXTON, Pa., April 24 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that two-thirds of surveyed U.S. rheumatologists believe that--at three months post launch--initiations of Pfizer's Xeljanz in the rheumatoid arthritis (RA) treatment...

2013-04-19 16:27:28

Research study online in JAMA Ophthalmology may herald new era of new highly targeted molecular treatment for common condition Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life. An estimated nine million people in the United State alone suffer from significant DED; millions more may have milder forms or experience discomfort when exposed to low humidity...

2013-04-04 11:41:15

Hormonal changes could precede development of the condition, say authors Low testosterone levels may herald the subsequent development of rheumatoid arthritis in men, suggests research published online in the Annals of the Rheumatic Diseases. Sex hormones are thought to play a part in the development of rheumatoid arthritis, and both men and women with the condition tend to have lower levels of testosterone in their blood than healthy people. But it is not clear whether this is a...

2013-04-03 16:24:21

BOCA RATON, Fla., April 3, 2013 /PRNewswire/ -- A panel of experts in health care and business today highlighted the impact of rheumatoid arthritis and other chronic conditions on employers and women in the workplace. Rheumatoid Arthritis (RA) attacks women at a rate three times more than men, and comes at a cost that goes way beyond physical pain. With women making up about 50 percent of the U.S. workforce, the impact of rheumatoid arthritis on workplace productivity exceeds 47 billion...

2013-03-27 16:27:43

HAYWARD, Calif., March 27, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced it has initiated the CHABLIS-SC1 Phase 3 study of blisibimod, a novel inhibitor of B-Cell Activating Factor (BAFF) for the treatment of systemic lupus erythematosus (lupus). Lupus is a chronic autoimmune disease, which often leads to severe skin rash, fatigue,...

2013-03-25 12:27:01

NORWALK, Conn., March 25, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network highlights growing evidence supporting the idea that many conditions related to arthritis are caused by cross-reactions between immune responses against infections and damage to the body's own tissues. Diseases such as rheumatoid arthritis and lupus may be an indication of a defect in the body's ability to fight infection, rather than an over-reaction to it, writes rheumatologist Stephen Paget...

2013-03-25 08:27:52

Lead product, lifitegrast ophthalmic solution for the treatment of dry eye, will expand Shire's presence in ophthalmology BRISBANE, Calif., March 25, 2013 /PRNewswire/ -- SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a global specialty biopharmaceutical company focused on enabling people with life-altering conditions to lead better lives. SARcode's lead program, lifitegrast ophthalmic solution,...

2013-03-22 08:24:55

HAYWARD, Calif., March 22, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced its abstract entitled "Blisibimod, an Emerging Subcutaneous Biologic Therapy for Patients with Active, Moderate-to-Severe Systemic Lupus Erythematosus," has been selected as an oral presentation and will be presented at the 10th International Congress on...

2013-03-18 15:52:32

Researchers in Manchester have found a link between several lifestyle factors and pre-existing conditions, including smoking cigarettes and diabetes, and an increased risk of developing rheumatoid arthritis. Rheumatoid Arthritis (RA) is a chronic disease which affects around 0.8% of the population; and its causes are of great interest to the medical world. Research led by Professor Ian Bruce, NIHR Senior Investigator and Professor of Rheumatology at The University of Manchester and...